“Importantly, the resolution agreements clearly define how we and our key competitors will interact with physician collaborators, thereby establishing a standard of conduct across the industry.”

— David Dvorak, president/CEO of Zimmer, commenting on settlements between it and the U.S. Department of Justice, “Implant makers to resolve fraud cases, will pay DoJ $311 million,” pp. 1, 6, 10.